Literature DB >> 32580949

NitroSpeed-Carba NP Test for Rapid Detection and Differentiation between Different Classes of Carbapenemases in Enterobacterales.

Patrice Nordmann1,2,3,4, Mustafa Sadek5, Anthony Demord3, Laurent Poirel5,2,3.   

Abstract

A biochemical test (NitroSpeed-Carba NP test) was developed to identify carbapenemase production in Enterobacterales and to discriminate between the different types of clinically significant carbapenemases (Ambler classes A, B, and D). It is based on two main features, namely, the hydrolysis by all β-lactamases, including carbapenemases of the nitrocefin substrate, and the capacity of ertapenem to prevent this hydrolysis for all β-lactamases except carbapenemases. Specific carbapenemase inhibitors of class A (avibactam, vaborbactam), class B (dipicolinic acid), and class D (avibactam) were used to inhibit the nitrocefin hydrolysis and to allow the identification of the carbapenemase types with a turnaround time of ca. 30 min. The test was evaluated with a collection of 248 clinical enterobacterial isolates, including 148 carbapenemase producers and 100 non-carbapenemase producers. Its overall sensitivity and specificity were 100% and 97%, respectively, including detection of all types of OXA-48-like carbapenemases. For the detection of the carbapenemase type, including strains that produce double carbapenemases, the sensitivity was 100%, 97%, and 100% for the detection of classes A, B, and D, respectively. This easy-to-implement test may contribute to optimization of the choice of the β-lactam/β-lactamase inhibitor combinations for treating infection due to carbapenemase producers.
Copyright © 2020 Nordmann et al.

Entities:  

Keywords:  Carba NP; Enterobacteraleszzm321990; UltraSpeed; carbapenemase; diagnostics; rapid

Mesh:

Substances:

Year:  2020        PMID: 32580949      PMCID: PMC7448648          DOI: 10.1128/JCM.00932-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

Review 1.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

2.  Carbapenem-resistant Enterobacteriaceae: a potential threat.

Authors:  Mitchell J Schwaber; Yehuda Carmeli
Journal:  JAMA       Date:  2008-12-24       Impact factor: 56.272

Review 3.  Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.

Authors:  Pranita D Tamma; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

4.  Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases.

Authors:  Scott J Hecker; K Raja Reddy; Maxim Totrov; Gavin C Hirst; Olga Lomovskaya; David C Griffith; Paula King; Ruslan Tsivkovski; Dongxu Sun; Mojgan Sabet; Ziad Tarazi; Matthew C Clifton; Kateri Atkins; Amy Raymond; Kristy T Potts; Jan Abendroth; Serge H Boyer; Jeffrey S Loutit; Elizabeth E Morgan; Stephanie Durso; Michael N Dudley
Journal:  J Med Chem       Date:  2015-03-17       Impact factor: 7.446

Review 5.  Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.

Authors:  T Tängdén; C G Giske
Journal:  J Intern Med       Date:  2015-01-27       Impact factor: 8.989

6.  Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections.

Authors:  Renee Ackley; Danya Roshdy; Jacqueline Meredith; Sarah Minor; William E Anderson; Gerald A Capraro; Christopher Polk
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

7.  Combined porin loss and extended spectrum beta-lactamase production is associated with an increasing imipenem minimal inhibitory concentration in clinical Klebsiella pneumoniae strains.

Authors:  Duo Yang; Yu Guo; Zheng Zhang
Journal:  Curr Microbiol       Date:  2009-02-14       Impact factor: 2.188

8.  Nitro-Carba test, a novel and simple chromogenic phenotypic method for rapid screening of carbapenemase-producing Enterobacteriaceae.

Authors:  Yothin Teethaisong; Ismini Nakouti; Katie Evans; Griangsak Eumkeb; Glyn Hobbs
Journal:  J Glob Antimicrob Resist       Date:  2019-01-19       Impact factor: 4.035

Review 9.  New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.

Authors:  Sarah M Drawz; Krisztina M Papp-Wallace; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

Review 10.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

View more
  6 in total

1.  Cross-Border Emergence of Escherichia coli Producing the Carbapenemase NDM-5 in Switzerland and Germany.

Authors:  Trinad Chakraborty; Mustafa Sadek; Yancheng Yao; Can Imirzalioglu; Roger Stephan; Laurent Poirel; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

2.  Multi Evaluation of a Modified GoldNano Carb Test for Carbapenemase Detection in Clinical Isolates of Gram-Negative Bacilli.

Authors:  Arpasiri Srisrattakarn; Aroonlug Lulitanond; Nicha Charoensri; Lumyai Wonglakorn; Suthida Kenprom; Chutipapa Sukkasem; Waewta Kuwatjanakul; Sirikan Piyapatthanakul; Onphailin Luanphairin; Wichuda Phukaw; Kunthida Khanchai; Jantira Pasuram; Chotechana Wilailuckana; Jureerut Daduang; Aroonwadee Chanawong
Journal:  Antibiotics (Basel)       Date:  2022-05-18

3.  Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice.

Authors:  Zhijie Zhang; Dayan Wang; Yahui Li; Yong Liu; Xiaosong Qin
Journal:  Front Cell Infect Microbiol       Date:  2022-02-21       Impact factor: 5.293

4.  Rapid Detection of bla KPC, bla NDM, bla OXA-48-like and bla IMP Carbapenemases in Enterobacterales Using Recombinase Polymerase Amplification Combined With Lateral Flow Strip.

Authors:  Fang Wang; Lei Wang; Huimin Chen; Na Li; Yan Wang; Yan Li; Wei Liang
Journal:  Front Cell Infect Microbiol       Date:  2021-12-02       Impact factor: 5.293

5.  Occurrence of Aztreonam-Avibactam-Resistant NDM-5-Producing Escherichia coli in the Food Chain.

Authors:  Mustafa Sadek; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

Review 6.  Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review.

Authors:  Alexis Tabah; Jeffrey Lipman; François Barbier; Niccolò Buetti; Jean-François Timsit
Journal:  Antibiotics (Basel)       Date:  2022-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.